STRS Ohio’s Heron Therapeutics HRTX Stock Holding History

STRS Ohio’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,100	Closed	-$94K	–	2277
2021 Q2	$94K	Buy	+6,100	New	+$97K	﹤0.01%	1987
2020 Q3	–	Sell	-9,900	Closed	-$145K	–	2232
2020 Q2	$145K	Buy	+9,900	New	+$163K	﹤0.01%	1710
2016 Q1	–	Sell	-12,100	Closed	-$239K	–	1911
2015 Q4	$323K	Sell	12,100 -14,300	-54%	-$382K	﹤0.01%	1409
2015 Q3	$644K	Hold	26,400	–	–	﹤0.01%	1116
2015 Q2	$822K	Buy	+26,400	New	+$497K	﹤0.01%	994

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

STRS Ohio's HRTX Position: Q3 2021 in Review

STRS Ohio sold out of Heron Therapeutics (HRTX) in Q3 2021, closing a stake of 6,100 shares — an estimated $94K sold.

STRS Ohio first reported a position in HRTX in Q2 2015 and held it in 5 quarters. The position peaked at $822K in Q2 2015. 197 funds tracked by Wall St. Rank hold HRTX as of Q3 2021.

STRS Ohio reported no remaining Heron Therapeutics position as of Q3 2021 after selling out during the quarter.
STRS Ohio sold 6,100 Heron Therapeutics shares in Q3 2021, an estimated $94K.
STRS Ohio first reported a position in Heron Therapeutics in Q2 2015 and held it in 5 quarters.
STRS Ohio's Heron Therapeutics position peaked at $822K in Q2 2015.
197 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2021.

Based on STRS Ohio's 13F filing for Q3 2021, filed 22 Oct 2021.